Apollo Hospitals Enterprise Limited has scheduled a conference call for analysts and investors on August 13, 2026, at 3:00 PM IST to discuss the unaudited financial results for the quarter ended June 30, 2026. The earnings call follows the board meeting scheduled for August 12, 2026, where the company will declare its financial results for the first quarter of FY27. This development is significant for stakeholders monitoring the healthcare major's operational performance and financial health.

Key Meeting Details

The board meeting to review the financial results is set for August 12, 2026. The subsequent earnings call will provide a platform for management to elaborate on the quarterly performance. Key details regarding the conference call are outlined below:

Conference Call Access

Participants can join the discussion via various dial-in numbers provided for different regions. Pre-registration is available to facilitate direct connection without operator assistance.

Management Representation

The conference call will feature key executives from Apollo Hospitals, including Mrs. Suneeta Reddy (Managing Director), Mr. A. Krishnan (Group CFO), and divisional CEOs such as Dr. Madhu Sasidhar and Mr. Madhivanan Balakrishnan. Their participation will offer insights into the company's strategic direction and operational metrics across its hospital, pharmacy, and diagnostics businesses.

Apollo Hospitals Enterprise Ltd. witnessed a notable block trade on the National Stock Exchange (NSE), with a transaction valued at ₹36.20 crores. The trade involved approximately 40,977 shares executed at a price of ₹8834.00 per share, marking a significant single-transaction activity in the stock.

Block Trade Details

The following table summarizes the key parameters of the block trade recorded for Apollo Hospitals Enterprise Ltd. on the NSE:

Block trades are large-volume transactions typically executed outside the regular market order book, often involving institutional investors or significant stakeholders. The execution of such a trade in Apollo Hospitals Enterprise Ltd. at ₹8834.00 per share underscores the scale of participation observed in this transaction.